Beg, M. S., Huang, X., Silvers, M. A., Gerber, D. E., Bolluyt, J., Sarode, V., . . . Boothman, D. A. (2017). Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in Pancreatic Cancer. J Surg Oncol.
Citação norma ChicagoBeg, Muhammad Shaalan, et al. "Using a Novel NQO1 Bioactivatable Drug, Beta-lapachone (ARQ761), to Enhance Chemotherapeutic Effects By Metabolic Modulation in Pancreatic Cancer." J Surg Oncol 2017.
MLA CitationBeg, Muhammad Shaalan, et al. "Using a Novel NQO1 Bioactivatable Drug, Beta-lapachone (ARQ761), to Enhance Chemotherapeutic Effects By Metabolic Modulation in Pancreatic Cancer." J Surg Oncol 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.